INTERLEUKIN 12 FUNCTION DURING MURINE LEISHMANIASIS
INTERLEUKIN 12 FUNCTION DURING MURINE LEISHMANIASIS
批准号:
2517108
负责人:
FREDERICK P. HEINZEL
金额:
$6.87万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-01 至 1999-08-31
关键词:
B lymphocyte CD4 molecule Leishmania major SCID mouse T lymphocyte athymic mouse cellular immunity density gradient ultracentrifugation enzyme linked immunosorbent assay flow cytometry gel electrophoresis immunotherapy interferon gamma interleukin 12 leishmaniasis leukocyte activation /transformation lymphocyte proliferation macrophage nucleic acid hybridization parasitic disease chemotherapy polymerase chain reaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cure and progression of murine leishmaniasis are mediated by reciprocal
expansions of functionally distinct Th1 and Th2 CD4+ lymphocyte subsets.
The long term goal of these studies is to understand cytokine-based
mechanisms responsible for biased CD4+ subset responses. The immediate
goals are to characterize the function and regulation of IL-12 during
leishmaniasis. The requested salary support will provide protected
research time necessary to perform the studies described, to develop an
independent career and to strengthen collaborations within the applicant
institution that will enhance both personal and institutional goals. CWRU
School of Medicine is committed to immunoparasitologic research and
provides a productive supportive environment for career development in
this field, as indicated by the existence of a free -standing Division
of Geographic Medicine and by the assignment of the P.I. to a tenure
track position.
We propose that IL-12 produced in response to infection critically
regulates CD4+ lymphocyte responses in vivo. IL-12 is a heterodimeric
T-cell growth and IFN-gamma stimulatory cytokine that is produced by B-
cells and macrophages. Preliminary studies show that treatment of
susceptible BALB/c mice with recombinant IL-12 restores fully curative
Th1 immunity during infection with L. major. Moreover, the production
of IL-12 is increased significantly in healing C57BL/6 mice compared to
nonhealing BALB/c mice. We hypothesize that IL-12 produced during
infection promotes curative CD4+ Th1 responses and that differences in
the production of IL-12 by infected BALB/c and C57BL/6 mice account for
their disparate responses to leishmaniasis. The proposed studies of IL-
12 production and function in BALB/c and C57BL/6 mice during
leishmaniasis may provide unique mechanistic insights into how parasitic
infection effects Th1 and Th2 responses that determine the course of
disease.
Specific aims are to:
1) Examine the role of IL-12 in promoting Th1 CD4+ subset selection and
curative immunity in BALB/c and C57BL/6 mice infected with Leishmania
major.
2) Identify differences in the production of IL-12 by BALB/c and C57BL/6
mice during leishmaniasis.
3) Analyze the role of IL-12 in the in vitro differentiation of L major
- specific CD4+ T cell subsets.
4) Identify stimuli that result in IL-12 release by B-lymphocytes and
macrophages during murine leishmaniasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENDOTOXIN TOLERANCE AS A MODEL FOR IMMUNE PARALYSIS
-
批准号:6127300
-
项目类别:
-
资助金额:$25.41万
-
财政年份:2000
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
ENDOTOXIN TOLERANCE AS A MODEL FOR IMMUNE PARALYSIS
-
批准号:6632103
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2000
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
ENDOTOXIN TOLERANCE AS A MODEL FOR IMMUNE PARALYSIS
-
批准号:6511013
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2000
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
ENDOTOXIN TOLERANCE AS A MODEL FOR IMMUNE PARALYSIS
-
批准号:6362421
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2000
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN 12 FUNCTION DURING MURINE LEISHMANIASIS
-
批准号:2057400
-
项目类别:
-
资助金额:$6.81万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN-12 AS IMMUNOTHERAPY IN LEISHMANIASIS
-
批准号:2071988
-
项目类别:
-
资助金额:$12.06万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN 12 FUNCTION DURING MURINE LEISHMANIASIS
-
批准号:2057398
-
项目类别:
-
资助金额:$6.71万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN 12 FUNCTION DURING MURINE LEISHMANIASIS
-
批准号:2057399
-
项目类别:
-
资助金额:$6.7万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN 12 AS IMMUNOTHERAPY IN LEISHMANIASIS
-
批准号:2886914
-
项目类别:
-
资助金额:$20.64万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN 12 AS IMMUNOTHERAPY IN LEISHMANIASIS
-
批准号:6169986
-
项目类别:
-
资助金额:$20.97万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN-12 AS IMMUNOTHERAPY IN LEISHMANIASIS
-
批准号:2071989
-
项目类别:
-
资助金额:$12.92万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN 12 FUNCTION DURING MURINE LEISHMANIASIS
-
批准号:2671352
-
项目类别:
-
资助金额:$6.93万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN 12 AS IMMUNOTHERAPY IN LEISHMANIASIS
-
批准号:6373389
-
项目类别:
-
资助金额:$21.59万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN-12 AS IMMUNOTHERAPY IN LEISHMANIASIS
-
批准号:2429425
-
项目类别:
-
资助金额:$13.47万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN 12 AS IMMUNOTHERAPY IN LEISHMANIASIS
-
批准号:2611255
-
项目类别:
-
资助金额:$15.99万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
INTERLEUKIN-12 AS IMMUNOTHERAPY IN LEISHMANIASIS
-
批准号:2071987
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
CYTOKINE FUNCTION DURING MURINE LEISHMANIASIS
-
批准号:3455013
-
项目类别:
-
资助金额:$7.94万
-
财政年份:1988
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
CYTOKINE FUNCTION DURING LEISHMANIASIS
-
批准号:3455009
-
项目类别:
-
资助金额:$7.83万
-
财政年份:1988
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
CYTOKINE FUNCTION DURING MURINE LEISHMANIASIS
-
批准号:3455012
-
项目类别:
-
资助金额:$8.19万
-
财政年份:1988
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
CYTOKINE FUNCTION DURING LEISHMANIASIS
-
批准号:3455010
-
项目类别:
-
资助金额:$8.26万
-
财政年份:1988
-
负责人:FREDERICK P. HEINZEL
-
依托单位:
海外基金